Brannin McBee - 30 Sep 2025 Form 4 Insider Report for CoreWeave, Inc. (CRWV)

Role
Chief Development Officer
Signature
/s/ Kristen McVeety, as Attorney-in-Fact
Issuer symbol
CRWV
Transactions as of
30 Sep 2025
Net transactions value
-$42,599,731
Form type
4
Filing time
02 Oct 2025, 18:47:02 UTC
Previous filing
25 Sep 2025
Next filing
20 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McBee Brannin Chief Development Officer C/O COREWEAVE, INC., 290 WEST MT. PLEASANT AVENUE, SUITE 4100, LIVINGSTON /s/ Kristen McVeety, as Attorney-in-Fact 02 Oct 2025 0002058103

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRWV Class A Common Stock Options Exercise $0 +11,739 +9.6% $0.000000 133,704 30 Sep 2025 Direct
transaction CRWV Class A Common Stock Options Exercise $0 +109,380 +82% $0.000000 243,084 30 Sep 2025 Direct
transaction CRWV Class A Common Stock Sale $8,073,994 -57,903 -24% $139.44 185,181 30 Sep 2025 Direct F1
transaction CRWV Class A Common Stock Conversion of derivative security +100,000 +54% 285,181 30 Sep 2025 Direct F2
transaction CRWV Class A Common Stock Conversion of derivative security +150,000 150,000 30 Sep 2025 Brannin J. McBee 2022 Irrevocable Trust F2, F3
transaction CRWV Class A Common Stock Sale $26,831 -200 -0.07% $134.16 284,981 30 Sep 2025 Direct F4, F5
transaction CRWV Class A Common Stock Sale $54,003 -400 -0.14% $135.01 284,581 30 Sep 2025 Direct F4, F6
transaction CRWV Class A Common Stock Sale $5,496,702 -40,187 -14% $136.78 244,394 30 Sep 2025 Direct F4, F7
transaction CRWV Class A Common Stock Sale $2,710,336 -19,676 -8.1% $137.75 224,718 30 Sep 2025 Direct F4, F8
transaction CRWV Class A Common Stock Sale $2,167,619 -15,638 -7% $138.61 209,080 30 Sep 2025 Direct F4, F9
transaction CRWV Class A Common Stock Sale $1,496,033 -10,715 -5.1% $139.62 198,365 30 Sep 2025 Direct F4, F10
transaction CRWV Class A Common Stock Sale $1,438,858 -10,221 -5.2% $140.77 188,144 30 Sep 2025 Direct F4, F11
transaction CRWV Class A Common Stock Sale $357,242 -2,523 -1.3% $141.59 185,621 30 Sep 2025 Direct F4, F12
transaction CRWV Class A Common Stock Sale $62,672 -440 -0.24% $142.44 185,181 30 Sep 2025 Direct F4, F13
transaction CRWV Class A Common Stock Sale $40,247 -300 -0.2% $134.16 149,700 30 Sep 2025 Brannin J. McBee 2022 Irrevocable Trust F3, F4, F5
transaction CRWV Class A Common Stock Sale $81,005 -600 -0.4% $135.01 149,100 30 Sep 2025 Brannin J. McBee 2022 Irrevocable Trust F3, F4, F6
transaction CRWV Class A Common Stock Sale $8,245,121 -60,281 -40% $136.78 88,819 30 Sep 2025 Brannin J. McBee 2022 Irrevocable Trust F3, F4, F7
transaction CRWV Class A Common Stock Sale $4,065,503 -29,514 -33% $137.75 59,305 30 Sep 2025 Brannin J. McBee 2022 Irrevocable Trust F3, F4, F8
transaction CRWV Class A Common Stock Sale $3,251,288 -23,456 -40% $138.61 35,849 30 Sep 2025 Brannin J. McBee 2022 Irrevocable Trust F3, F4, F9
transaction CRWV Class A Common Stock Sale $2,244,258 -16,074 -45% $139.62 19,775 30 Sep 2025 Brannin J. McBee 2022 Irrevocable Trust F3, F4, F10
transaction CRWV Class A Common Stock Sale $2,158,076 -15,330 -78% $140.77 4,445 30 Sep 2025 Brannin J. McBee 2022 Irrevocable Trust F3, F4, F11
transaction CRWV Class A Common Stock Sale $535,934 -3,785 -85% $141.59 660 30 Sep 2025 Brannin J. McBee 2022 Irrevocable Trust F3, F4, F12
transaction CRWV Class A Common Stock Sale $94,009 -660 -100% $142.44 0 30 Sep 2025 Brannin J. McBee 2022 Irrevocable Trust F3, F4, F13
holding CRWV Class A Common Stock 60,000 30 Sep 2025 Canis Major SM Trust F14
holding CRWV Class A Common Stock 1,800 30 Sep 2025 See Footnote F15

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRWV Restricted Stock Units Options Exercise $0 -11,739 -6.7% $0.000000 164,343 30 Sep 2025 Class A Common Stock 11,739 Direct F16, F17, F18
transaction CRWV Restricted Stock Units Options Exercise $0 -109,380 -7.1% $0.000000 1,421,880 30 Sep 2025 Class A Common Stock 109,380 Direct F16, F18, F19
transaction CRWV Class B Common Stock Conversion of derivative security -100,000 -0.99% 10,042,260 30 Sep 2025 Class A Common Stock 100,000 Direct F2
transaction CRWV Class B Common Stock Conversion of derivative security -150,000 -3.4% 4,266,020 30 Sep 2025 Class A Common Stock 150,000 Brannin J. McBee 2022 Irrevocable Trust F2, F3
holding CRWV Class B Common Stock 2,300,300 30 Sep 2025 Class A Common Stock 2,300,300 By Spouse F2, F20
holding CRWV Class B Common Stock 104,000 30 Sep 2025 Class A Common Stock 104,000 Canis Major 2025 Family Trust LLC F2, F21
holding CRWV Class B Common Stock 6,000,000 30 Sep 2025 Class A Common Stock 6,000,000 Canis Major 2025 GRAT F2, F22
holding CRWV Class B Common Stock 360,000 30 Sep 2025 Class A Common Stock 360,000 Canis Major 2024 Irrevocable Trust LLC F2, F23
holding CRWV Class B Common Stock 114,000 30 Sep 2025 Class A Common Stock 114,000 Canis Minor 2025 Family Trust LLC F2, F24
holding CRWV Class B Common Stock 1,000,000 30 Sep 2025 Class A Common Stock 1,000,000 Canis Minor 2025 GRAT F2, F25
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.
F2 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
F3 The reported securities are directly held by the Brannin J. McBee 2022 Irrevocable Trust, of which the reporting person's spouse and minor child are beneficiaries and for which the reporting person's spouse serves as trustee.
F4 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2025.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.61 to $134.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 6 through 13.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.63 to $135.35, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.23 to $137.22, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.23 to $138.22, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.23 to $139.22, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.23 to $140.21, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.23 to $141.21, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.23 to $142.22, inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.24 to $142.63, inclusive.
F14 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.
F15 The reported securities are directly held of record by the reporting person's minor child.
F16 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.
F17 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.
F18 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.
F19 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.
F20 The reported securities are directly held by the reporting person's spouse.
F21 The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.
F22 The reported securities are directly held by the Canis Major 2025 GRAT, of which the reporting person is the sole trustee and beneficiary.
F23 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager.
F24 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.
F25 The reported securities are directly held by the Canis Minor 2025 GRAT, of which the reporting person's spouse is the sole beneficiary and trustee.